Home     Media Contacts     Links     Sitemap     MRMC globe4.gif     MEDCOM globe4.gif     Army globe4.gif     AKO globe4.gif     CTC globe4.gif     FAQ          
HOME>>Re&Develop>>Infectious Disease>>Viral Diseases Sunday, October 21 2018

Skip Navigation Links
Viral Diseases Branch
We are the Viral Diseases Branch. We protect and sustain the health of the US military through the conduct of high quality, strategic, and mission relevant infectious diseases research with a focus on viral diseases. We carry out our mission by developing and testing therapeutic and preventative drugs and vaccines, supporting global infectious diseases surveillance, completing detailed pathogen and disease description, and educating and training the next generation of world class scientists and research support personnel. The Viral Diseases Branch is committed to developing the products which protect the men and women who protect our Nation.
  • Dengue:The most important mosquito borne virus in the world and #2 infectious diseases threat to the US military. Fifty to 100 million new infections occur annually in over 120 countries resulting in millions of hospitalizations and tens of thousands of deaths. Dengue decimated U.S. and allied forces fighting strength in the Pacific theater during WWII and accounted for 20-30% of undifferentiated fever in Vietnam, Somalia, and Haiti. Recent outbreaks in Hawaii, Florida, and southern Texas, persistent high-level transmission in Puerto Rico, and the mosquito vector's presence in large regions of the U.S demonstrate an emerging domestic risk.
  • Adenovirus:The leading cause of Acute Respiratory Disease (ARD) among basic trainees accounting for thousands of hospitalizations and occasional deaths, reducing training efficiency and increasing health care and training costs. VDB led the successful DoD effort to develop and license (2011) vaccines against adenovirus types 4 and 7. New types (i.e. 14 and 21) emerging as causes of illness in both military (recruits) and civilian special populations.
  • Respiratory Infections and Disease non-Adenovirus: Respiratory infections cause 25-30% of infectious disease hospitalizations in the military, second only to injury as a cause of DNBI among deployed forces. Clear strategic threat associated with pandemic potential of influenza and other respiratory pathogens. Constrictive bronchiolitis associated with deployment to OIF/OEF, etiology undefined, remains a concern.
Major Development Accomplishments (year of vaccine licensure)
  • The first influenza vaccine (1948)
  • Hepatitis A Vaccine (1995)
  • An oral type 4 and 7 Adenovirus Vaccine (1980), next generation vaccine (2011)
  • Japanese Encephalitis Virus vaccine (1992), next generation (2009)
Current Programmatic Focus
  • Dengue:Continue work within MIDRP and with industry partners to develop a safe, efficacious, US FDA licensed dengue vaccine for the Warfighter.
  • Adenovirus:Measure impact of current vaccine roll out, explore development of next generation vaccine with expanded protection profile.
  • Respiratory Infections:Support global surveillance of respiratory viral disease threats, contribute to influenza virus strain selection, identify and characterize evolving threats ahead of pandemic.
  • Pathogen Discovery:Leverage Branch's high throughput sequencing platforms to identify and characterize pathogens un-typable by routine laboratory methods, supports multiple Branches in the WRAIR enterprise.
  • Operational Research:Special projects embedded with operational units to define risk and operational impact.
Contact Viral Diseases Branch
Viral Diseases Branch
(301) 319-9210

Last Modified Date: 09-September-2016

This Web site provides an introduction to the U.S. Army Medical Research and Materiel Command (USAMRMC) and contains official Government information. Its use is intended for members of the general public, news media and Army Medical Department beneficiaries.
Please address questions or concerns about this website to the Public Affairs Office via e-mail or by telephone at 301-319-9471.